Your browser doesn't support javascript.
loading
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.
Chakraborty, Goutam; Armenia, Joshua; Mazzu, Ying Z; Nandakumar, Subhiksha; Stopsack, Konrad H; Atiq, Mohammad O; Komura, Kazumasa; Jehane, Lina; Hirani, Rahim; Chadalavada, Kalyani; Yoshikawa, Yuki; Khan, Nabeela A; Chen, Yu; Abida, Wassim; Mucci, Lorelei A; Lee, Gwo-Shu Mary; Nanjangud, Gouri J; Kantoff, Philip W.
Afiliación
  • Chakraborty G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Armenia J; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mazzu YZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nandakumar S; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Stopsack KH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Atiq MO; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Komura K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jehane L; Department of Urology, Osaka Medical College, Osaka, Japan.
  • Hirani R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chadalavada K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yoshikawa Y; Molecular Cytogenetics Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Khan NA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chen Y; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Abida W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mucci LA; Human Oncology Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lee GM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nanjangud GJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Kantoff PW; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
Clin Cancer Res ; 26(8): 2047-2064, 2020 04 15.
Article en En | MEDLINE | ID: mdl-31796516
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article